Arcutis Biotherapeutics Inc

+0.11 (+0.60%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.10B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.82 Million
Adjusted EPS-$1.54
See more estimates
10-Day MA$18.97
50-Day MA$22.66
200-Day MA$19.93
See more pivots

Arcutis Biotherapeutics Inc Stock, NASDAQ:ARQT

3027 Townsgate Road, Suite 300, Westlake Village, California 91361
United States of America
Phone: +1.805.418.5006
Number of Employees: 147


Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.